
Tatiana Prowell/Medscape
Aug 20, 2025, 14:33
Tatiana Prowell: New FDA Draft Guidance on Overall Survival in Oncology Clinical Trials
Tatiana Prowell, Associate Professor of Oncology at Johns Hopkins School of Medicine and Breast Cancer Scientific Liaison at the U.S. Food and Drug Administration, shared a post on X:
“NEW FDA Draft Guidance on Overall Survival in Oncology Clinical Trials, covering trial design, biostats considerations, posthoc and subgroup analyses, and more. Public comment period open now thru 10/20/2025.”
More posts featuring Tatiana Prowell on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 20, 2025, 14:24
Aug 20, 2025, 14:12
Aug 20, 2025, 14:02
Aug 20, 2025, 13:59
Aug 20, 2025, 13:51
Aug 20, 2025, 13:46